Assessment of low vitamin D among Saudi Arabians: Did we overshoot the runway?

Saudi Medical Journal

Volumn 35, Issue 10, 2014, Pages 1243-1249

  Sadat Ali, Mir ^a   Al Elq, Abdulmohsen H ^a   Al Shaikh, Iman H ^a   Al Turk, Haifa A ^a   Al Ali, Amein K ^a   Al Othman, Abdallah A ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; IMMUNOGLOBULIN G; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIBLIOGRAPHIC DATABASE; CALCIUM BLOOD LEVEL; CHEMILUMINESCENCE IMMUNOASSAY; CROSS-SECTIONAL STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; RADIOACTIVITY; RADIOIMMUNOASSAY; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; ADOLESCENT; AGED; ANALOGS AND DERIVATIVES; BLOOD; LUMINESCENCE; PREVALENCE; REFERENCE VALUE; SAUDI ARABIA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHROMATOGRAPHY, LIQUID; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; PREVALENCE; RADIOIMMUNOASSAY; REFERENCE VALUES; SAUDI ARABIA; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84949115142     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ryan JW, Anderson PH, Turner AG, Morris HA. Vitamin D activities and metabolic bone disease. Clin Chim Acta 2013; 425: 148-152.
2. Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 2011; 25: 585-591.
3. Wacker M, Holick MF. Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013; 5: 111-148.
4. Genc DB, Ozkan MA, Buyukgebiz A. Vitamin D in childhood cancer: a promising anticancer agent? Pediatr Endocrinol Rev 2013; 10: 485-493.
5. Gunta SS, Thadhani RI, Mak RH. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol 2013; 9: 337-347.
6. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362-371.
7. Ju SY, Lee YJ, Jeong SN. Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis. J Nutr Health Aging 2013; 17: 447-455.
8. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357: 266-281.
9. Binkley N, Ramamurthy R, Krueger D. Low vitamin D status: definition, prevalence, consequences, and correction. Rheum Dis Clin North Am 2012; 38: 45-59.
10. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr 2013; 9: 1-23.
11. Al-Turki H, Sadat-Ali M, Al-Elq A, Al-Mulhim F, Al-Ali M. 25-Hydroxy vitamin D levels among healthy Saudi Arabian women. Saudi Med J 2008; 29: 1765-1768.
12. Sadat-Ali M, Al-Elq AM, Al-Turki H, Al-Mulhim F, Al-Ali A. Vitamin D levels among Healthy Saudi Arabian Men. Ann Saudi Med 2009; 29: 378-382.
13. Ardawi MS, Qari MH, Rouzi AA, Maimani AA, Raddadi RM. Vitamin D status in relation to obesity, bone mineral density, bone turnover markers and vitamin D receptor genotypes in healthy Saudi pre- and postmenopausal women. Osteoporos Int 2011; 22: 463-475.
14. ElSammak MY, Al-Wossaibi AA, Al-Howeish A, Alsaeed J. Vitamin D deficiency in Saudi Arabs. Horm Metab Res 2010; 42: 1-5.
15. Al-Elq AM. The status of Vitamin D in medical students in the preclerkship years of a Saudi medical school. J Family Community Med 2012; 19: 100-104.
16. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 2006; 52: 1120-1126.
17. Binkley N, Krueger D, Cowgill C, Hansen KE, Drezner MK. Assay variation confounds hypovitaminosis D diagnosis: a call for standardization. J Clin Endocrinol Metab 2003; 89: 3152-3157.
18. Tsugawa N, Suhara Y, Kamao M, Okano T. Determination of 25-Hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry. Anal Chem 2005; 77: 3001-3007.
19. Wallace AM, Gibson S, de la Hunty A, Lamberg-Allardt C, Ashwell M. Measurement of 25-hydroxyvitamin D in the clinical laboratory: current procedures, performance characteristics and limitations. Steroids 2010; 75: 477-488.
20. Fraser WD, Milan AM. Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 2013; 92: 118-127.
21. Carter GD. Accuracy of 25-Hydroxyvitamin D Assays: Confronting the Issues. Curr Drug Targets 2011; 12: 19-28.
22. Carter GD, Carter R, Jones J, Berry J. How accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme. Clin Chem 2004; 50: 2195-2197.
23. Carter GD, Jones JC, Berry JI. The anomalous behaviour of exogenous 25-hydroxyvitamin D in competitive binding assays. J Steroid Biochem Mol Biol 2007; 103: 480-482.
24. He CS, Gleeson M, Fraser WD. Measurement of circulating 25-hydroxy vitamin d using three commercial enzymelinked immunosorbent assay kits with comparison to liquid chromatography: tandem mass spectrometry method. ISRN Nutr 2013; 2013: 723139.
25. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. Ann Clin Biochem 2008; 45 (Pt 2): 153-159.
26. Farrell CJ, Martin S, McWhinney B, Straub I, Williams P, Herrmann M. State-of-the-art vitamin D assays: a comparison of automated immunoassays with liquid chromatographytandem mass spectrometry methods. Clin Chem 2012; 58: 531-542.
27. Moon HW, Cho JH, Hur M, Song J, Oh GY, Park CM, Yun YM, Kim JQ. Comparison of four current 25-hydroxyvitamin D assays. Clin Biochem 2012; 45: 326-330.
28. Harrison SL, Nowak M, Buettner PG, Kimlin M, Proter D, Kennedy RL et al. Public health and clinical dilemmas resulting from imprecise vitamin D tests. J Rural Trop Public Health 2009; 8: 52-58.
29. Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, Wernroth L, et al. DeterminingVitamin D status: A comparison between commercially available assays. PLos One 2010; 5: e11555.
30. Lai JK, Lucas RM, Banks E, Ponsonby AL, Ausimmune Investigator Group. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 2012; 42: 43-50.
31. Holmes EW, Garbincius J, McKenna KM. Analytical variability among methods for the measurement of 25-hydroxyvitamin D: still adding to the noise. Am J Clin Pathol 2013; 140: 550-560.
32. Ong L, Saw S, Sahabdeen NB, Tey KT, Ho CS, Sethi SK. Current 25-hydroxyvitamin D assays: do they pass the test? Clin Chim Acta 2012; 413: 13-14.
33. Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR, Fraser WD, Vasikaran SD. Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assayspecific decision limits and metabolite-specific assays. Ann Clin Biochem 2006; 43 (Pt 1): 23-30.